1. Home
  2. GERN vs WGO Comparison

GERN vs WGO Comparison

Compare GERN & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.36

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Winnebago Industries Inc.

WGO

Winnebago Industries Inc.

HOLD

Current Price

$28.30

Market Cap

901.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GERN
WGO
Founded
1990
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
901.5M
IPO Year
1996
1994

Fundamental Metrics

Financial Performance
Metric
GERN
WGO
Price
$1.36
$28.30
Analyst Decision
Hold
Buy
Analyst Count
3
10
Target Price
$2.17
$42.78
AVG Volume (30 Days)
9.0M
438.2K
Earning Date
05-06-2026
03-25-2026
Dividend Yield
N/A
4.40%
EPS Growth
51.85
106.82
EPS
N/A
0.87
Revenue
$1,065,000.00
$1,985,674,000.00
Revenue This Year
$26.91
$5.10
Revenue Next Year
$43.75
$4.69
P/E Ratio
N/A
$33.07
Revenue Growth
N/A
N/A
52 Week Low
$1.04
$26.80
52 Week High
$2.01
$50.16

Technical Indicators

Market Signals
Indicator
GERN
WGO
Relative Strength Index (RSI) 40.83 36.69
Support Level $1.24 $27.24
Resistance Level $1.46 $32.46
Average True Range (ATR) 0.08 1.00
MACD -0.02 -0.32
Stochastic Oscillator 3.85 0.84

Price Performance

Historical Comparison
GERN
WGO

About GERN Geron Corporation

Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.

About WGO Winnebago Industries Inc.

Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was $2.8 billion in fiscal 2025. Winnebago expanded into towables in 2010 with the acquisition of SunnyBrook and acquired Grand Design in 2016. Towables made up 84% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total fiscal 2025 RV unit volume was 36,911. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in 2019, and acquired Barletta pontoon boats in 2021. It also is developing electric and autonomous technology.

Share on Social Networks: